Drug for Overactive Bladder Recommended in Europe
Obgemsa is suitable for treating symptoms of an overactive bladder in adults, the European Medicines Agency has determined.
Stay updated with breaking news from Human Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Obgemsa is suitable for treating symptoms of an overactive bladder in adults, the European Medicines Agency has determined.
New restrictions have been imposed by the European Medicines Agency on the coadministration of the anti-HIV drug atazanavir with a variety of other agents.
The drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's disease.
Forward-Looking Statements This call will have forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All...
/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the European Commission (EC) has approved a...